House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Neonatology

Neonatal infection: antibiotics for prevention and treatment

NICE · 2026 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

NICE NG195 links neonatal antibiotic decisions to maternal risk, the baby’s clinical findings, cultures and repeated assessment. It distinguishes early- and late-onset infection, specifies conditional stopping reviews, and adds a tightly defined oral step-down option for selected clinically well babies with suspected early infection and negative blood cultures.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Identify risk and act on the newborn’s condition

  • Offer intrapartum antibiotics for preterm labour, current pregnancy group B streptococcal colonization, bacteriuria or infection, a previous baby with invasive GBS disease, or chorioamnionitis. Previous-pregnancy GBS also qualifies unless appropriately timed current rectovaginal enrichment culture or PCR is negative. [1]
  • Start indicated intrapartum prophylaxis as soon as labour starts, or when chorioamnionitis is suspected, and continue until birth. Choose the regimen using the separate chorioamnionitis and allergy pathways; gentamicin or vancomycin may require drug monitoring. [1]
  • Assess maternal and neonatal history and vital signs immediately when early-infection risks or clinical indicators exist. Risk factors include spontaneous preterm birth, ruptured membranes over 18 hours before preterm birth or over 24 hours before term birth, maternal sepsis and chorioamnionitis. Infection in another baby of a multiple pregnancy is a red flag. [1]
  • Early-infection red flags include apnoea, seizures, cardiopulmonary resuscitation, mechanical ventilation or shock. Any red flag, or at least 2 non-red-flag risk factors or clinical indicators, warrants investigations and antibiotics without waiting for results. [1]
  • With only one risk factor or clinical indicator and no red flag, use clinical judgement about withholding antibiotics and observation. When observation is needed, monitor for at least 12 hours with a newborn early-warning system. Continue routine postnatal care if neither risk factors nor indicators are present. [1]
  • The Kaiser Permanente sepsis calculator is an alternative only for babies born after 34+0 weeks in the specified neonatal, transitional or postnatal settings and as part of a prospective audit, including missed culture-confirmed infections. Use its classification to direct management when choosing this approach. [1]
  • For late-onset infection, consider changes in behaviour, feeding, breathing, temperature or circulation. Prematurity, ventilation, surgery and central catheters increase risk. Seek early paediatric advice outside inpatient settings; babies presenting from home require the relevant infant sepsis pathway. [1]

Obtain cultures, assess meningitis and start treatment promptly

  • Take a blood culture before the first antibiotic dose and measure baseline CRP, using subsequent values alongside the clinical course. Do not use CRP alone to start, continue or stop antibiotics. When treatment is needed, give it as soon as possible and within 1 hour of the decision. [1]
  • Routine urine microscopy or culture is not indicated for early-onset infection or late-onset infection in a neonatal unit. For suspected late-onset infection outside neonatal units, investigate urine using the paediatric UTI pathway; avoid skin swabs without local signs. [1]
  • Perform lumbar puncture when safe if infection is strongly suspected or meningitis signs are present. First stabilize airway, breathing, shock, uncontrolled seizures and bleeding risk. Do not proceed with spreading purpura, local infection, an evolving space-occupying-lesion risk or signs suggesting raised intracranial pressure. [1]
  • Measure blood glucose immediately before lumbar puncture. Send CSF cell counts, protein, glucose, Gram stain, culture with sensitivities and relevant PCR. [1]
  • Interpret CSF using age-appropriate thresholds alongside the clinical presentation and maternal history. Account for blood contamination and reduced diagnostic reliability after earlier antibiotics. [1]
  • Reconsider lumbar puncture during treatment if initially omitted and safe, particularly with a positive culture other than coagulase-negative staphylococcus, inadequate treatment response, strong infection suspicion or meningitis signs. [1]

Review early-onset treatment and stopping eligibility

  • For empirical early-onset infection, use intravenous benzylpenicillin with gentamicin unless local resistance indicates another regimen. Microbiologically demonstrated gram-negative sepsis needs additional active coverage; stop benzylpenicillin if gram-negative infection is confirmed. [1]
  • For early-onset infection, stop intravenous antibiotics at 36 hours only when culture is negative, initial suspicion was not strong, the baby is clinically reassuring without infection indicators, and CRP levels and trends are reassuring. If continuing despite negative cultures, review the need at least daily. [1]
  • A positive blood culture or strongly suspected early sepsis generally warrants 7 days of intravenous treatment. Consider longer therapy if recovery is incomplete or the pathogen requires it, with expert advice; the specific oral step-down criteria apply only to eligible culture-negative babies. [1]

Apply every condition of the selected oral step-down pathway

  • For suspected early-onset neonatal infection, consider oral step-down at 36 hours or later only for babies born from 35+0 weeks with a negative blood culture who need longer treatment because initial suspicion was strong. The baby must be clinically reassuring without ongoing infection signs, have reassuring CRP levels and trends, and tolerate oral feeds; complete up to 7 days in total. [1]
  • For babies meeting the culture-negative early-onset oral-switch criteria, use oral amoxicillin unless local resistance requires another choice. A senior neonatologist or paediatrician must agree to both the switch and any discharge. The guideline does not supply a settled neonatal amoxicillin dose for this indication. [1]
  • Home oral treatment requires neonatal-team support, parent or carer training with a supervised first dose, clear access to help, addressed concerns and no other inpatient need. Provide at least 2 follow-up consultations, including one at treatment completion, to assess wellbeing and continuing antibiotic need. [1]

Distinguish neonatal-unit late infection and meningitis

  • For suspected late-onset infection in an existing neonatal-unit inpatient, use locally appropriate narrow-spectrum combination therapy covering gram-positive and gram-negative bacteria, such as intravenous flucloxacillin plus gentamicin. Add anaerobic activity if necrotising enterocolitis is suspected. This is not the admission-from-home regimen. [1]
  • For suspected late-onset infection, consider stopping at 48 hours when culture is negative, initial suspicion was not strong, clinical condition is reassuring without infection signs and CRP trends are reassuring. Continuing culture-negative treatment requires at least daily review. [1]
  • For late-onset infection with a positive blood culture, give 7 days and consider longer treatment for incomplete recovery, particular pathogens or deeper sites such as NEC, bone or catheter infection. A shorter course is appropriate after prompt recovery when no pathogen or only a common commensal is identified; meningitis follows its own duration pathway. [1]
  • During antibiotic treatment for suspected late-onset bacterial infection, give oral nystatin prophylaxis when birthweight is at most 1,500 g OR gestation was below 30 weeks. If oral nystatin is not possible, use intravenous fluconazole with clinical dosing judgement. [1]
  • In a neonatal unit, suspected meningitis with an unknown pathogen is treated with intravenous amoxicillin plus cefotaxime. Confirmed gram-negative meningitis permits cefotaxime alone; gram-positive findings require continued combination treatment and microbiology advice while awaiting culture. Organism-specific treatment and durations then govern care. [1]

Monitor gentamicin and plan recovery

  • If a second gentamicin dose is given, sample a trough immediately beforehand and use it before the third dose. Recheck immediately before every subsequent third dose, or more often for renal or concentration concerns. Adjust intervals toward a trough below 2 mg/L, and below 1 mg/L if the course exceeds 3 doses. [1]
  • Record administration and sampling times. Do not withhold gentamicin solely for a delayed trough result unless renal impairment is evident. Consider peak measurement in selected babies, including poor response or proven gram-negative infection; when measured, sample 1 hour after starting administration. [1]
  • After bacterial meningitis, arrange neurodevelopmental follow-up and audiology within 4 weeks of being well enough, preferably before discharge. Arrange paediatric review at 4–6 weeks and 1 year after discharge, and developmental surveillance for at least 2 years; communicate plans and a named contact to the family and primary-care team. [1]

Limitations and use

  • This selected neonatal pathway does not reproduce every maternal prophylaxis regimen, newborn risk indicator, antibiotic dose or organ-specific treatment course. Meningitis, confirmed bloodstream infection and unstable infants must not be managed using the culture-negative oral-switch pathway.
  • The oral step-down recommendation is a narrow eligibility option with senior review and structured follow-up. A reassuring CRP result alone is insufficient, and local microbiology may require a different agent.
  • Gentamicin starting doses, dosing intervals and peak-based adjustments require the complete neonatal prescribing and therapeutic-monitoring protocol, accounting for renal function and the indication.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Neonatal infection: antibiotics for prevention and treatment

    Selected recommendation material consulted

Clinical guideline

Publication details

Issuing organisation
NICE
First published
20 April 2021
Publisher’s latest update
13 May 2026
Resource type
Clinical guideline · House clinical summary
Source setting
United Kingdom

Earlier House summaries: neonatal infection nice

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Identify risk and act on the newborn’s condition
  • Obtain cultures, assess meningitis and start treatment promptly
  • Review early-onset treatment and stopping eligibility
  • Apply every condition of the selected oral step-down pathway
  • Distinguish neonatal-unit late infection and meningitis
  • Monitor gentamicin and plan recovery
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House